{"ORPHApacket":[{"ORPHApacketID":"217064","date":"2019-12-06 00:26:59","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"217064","Name":[{"lang":"en","label":"5-fluorouracil poisoning"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_217064","DisorderType":[{"Name":[{"lang":"en","label":"Particular clinical situation in a disease or syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377793"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare intoxication due to medical products"}],"ORPHA":"306640","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_306640"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"5-fluorouracil (5-FU) poisoning is a rare intoxication caused by the prolonged, low-dose administration of 5-FU, which is the mainstay of both adjuvant and advanced-disease chemotherapy regimens in colon cancer. 5-FU poisoning is characterized by gastrointestinal (nausea, emesis, diarrhea, anorexia, stomatitis) and hematologic (myelosuppression) toxicities as well as mucositis, alopecia and, occasionally, palmar-plantar dysesthesia (more commonly known as hand-foot syndrome). Women have been reported to experience more 5-FU-related toxicity than men."}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adult"}]},{"Name":[{"lang":"en","label":"Elderly"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"5-fluorouracil intoxication"}]}]}]}